Cytomegalovirus infection in early childhood may be protective against glioblastoma multiforme, while later infection is a risk factor

Medical Hypotheses

Volumn 78, Issue 5, 2012, Pages 657-658

  Lehrer, Steven ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

VIRUS DNA;

ADULTHOOD; ARTICLE; BLOOD CULTURE; CANCER RISK; CHILDHOOD DISEASE; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTION; EVIDENCE BASED PRACTICE; GLIOBLASTOMA; HUMAN; NONHUMAN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RISK FACTOR; SOCIAL STATUS; VIRUS DETECTION;

AGE FACTORS; BRAIN NEOPLASMS; CHILD, PRESCHOOL; CYTOMEGALOVIRUS; CYTOMEGALOVIRUS INFECTIONS; GLIOBLASTOMA; HUMANS; MODELS, BIOLOGICAL; POLIOMYELITIS; RISK FACTORS; SOCIAL CLASS;

CYTOMEGALOVIRUS;

EID: 84859265740     PISSN: 03069877     EISSN: 15322777     Source Type: Journal    
DOI: 10.1016/j.mehy.2012.02.003     Document Type: Article

References (11)

1. Mitchell D.A., Xie W., Schmittling R., Learn C., Friedman A., McLendon R.E., et al. Sensitive detection of human cytomegalovirus in tumors and peripheral blood of patients diagnosed with glioblastoma. Neuro Oncol 2008, 10(1):10-18.
2. Miller G. Brain cancer. A viral link to glioblastoma?. Science 2009, 323(5910):30-31.
3. Strandberg T.E., Pitkala K.H., Tilvis R.S. Cytomegalovirus antibody level and mortality among community-dwelling older adults with stable cardiovascular disease. JAMA 2009, 301(4):380-382.
4. Cobbs C.S., Harkins L., Samanta M., Gillespie G.Y., Bharara S., King P.H., et al. Human cytomegalovirus infection and expression in human malignant glioma. Cancer Res 2002, 62(12):3347-3350.
5. Lehrer S., Labombardi V., Green S., Pessin-Minsley M.S., Germano I.M., Rosenzweig K.E. No circulating cytomegalovirus in five patients with glioblastoma multiforme. Anticancer Res 2011, 31(3):959-960.
6. CBTRUS. Statistical Report: Primary Brain Tumors in the United States, 2000-2004. Hinsdale, Illinois: Central Brain Tumor Registry of the United States; 2008.
7. Chakrabarti I., Cockburn M., Cozen W., Wang Y.P., Preston-Martin S. A population-based description of glioblastoma multiforme in Los Angeles County, 1974-1999. Cancer 2005, 104(12):2798-2806.
8. Wigertz A., Lonn S., Hall P., Feychting M. Non-participant characteristics and the association between socioeconomic factors and brain tumour risk. J Epidemiol Community Health 2010, 64(8):736-743.
9. White N.H., Yow M.D., Demmler G.J., Norton H.J., Hoyle J., Pinckard K., et al. Prevalence of cytomegalovirus antibody in subjects between the ages of 6 and 22 Years. J Infect Dis 1989, 159(6):1013-1017.
10. Vinken P.J., Bruyn G.W., Klawans H.L., McKendall R.R. Viral disease 1989, Elsevier, p. 315.
11. Paya C., Humar A., Dominguez E., Washburn K., Blumberg E., Alexander B., et al. Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients. Am J Transplant 2004, 4(4):611-620.